Hepatocellular carcinoma: Intratumoral EpCAM-positive cancer stem cell heterogeneity identifies high-risk tumor subtype

被引：0

作者：

Jenny Krause

Johann von Felden

Christian Casar

Thorben W. Fründt

Johanna Galaski

Constantin Schmidt

Caroline Jung

Harald Ittrich

Sören A. Weidemann

Till Krech

Asmus Heumann

Jun Li

Lutz Fischer

Guido Sauter

Ansgar W. Lohse

Henning Wege

Kornelius Schulze

机构：

[1] University Medical Centre Hamburg-Eppendorf,Department of Medicine

[2] University Medical Centre Hamburg-Eppendorf,Bioinformatics Core

[3] University Medical Centre Hamburg-Eppendorf,Department of Diagnostic and Interventional Radiology and Nuclear Medicine

[4] University Medical Centre Hamburg-Eppendorf,Department of Pathology

[5] University Medical Centre Hamburg-Eppendorf,Department of General, Visceral and Thoracic Surgery

[6] University Medical Centre Hamburg-Eppendorf,Department of Visceral Transplant Surgery

[7] University Medical Centre Hamburg-Eppendorf,Mildred Scheel Cancer Career Centre HaTriCS4

来源：

BMC Cancer | / 20卷

关键词：

Hepatocellular carcinoma; Cancer stem cell features; EpCAM; Intratumoral heterogeneity;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Stem-cell transplantation for high-risk breast cancer
Elfenbein, GJ
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (01): : 80 - 82
[22] Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer
Park, So Yeon
Lee, Hee Eun
Li, Hailun
Shipitsin, Michail
Gelman, Rebecca
Polyak, Kornelia
CLINICAL CANCER RESEARCH, 2010, 16 (03) : 876 - 887
[23] Targeting liver cancer stem cell through EpCAM therapy targeted with chemotherapy endorse enhanced progression in hepatocellular carcinoma
Sekar, Vasanthakumar
Veerabathiran, Ramakrishnan
Pandian, Arjun
Sivamani, Ganesan
EGYPTIAN LIVER JOURNAL, 2023, 13 (01)
[24] Targeting liver cancer stem cell through EpCAM therapy targeted with chemotherapy endorse enhanced progression in hepatocellular carcinoma
Vasanthakumar Sekar
Ramakrishnan Veerabathiran
Arjun Pandian
Ganesan Sivamani
Egyptian Liver Journal, 13
[25] Primary Cutaneous Carcinosarcoma of the Basal Cell Subtype Should Be Treated as a High-Risk Basal Cell Carcinoma
Bourgeault, Emilie
Alain, Jimmy
Gagne, Eric
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2015, 19 (04) : 407 - 411
[26] Non-alcoholic steatohepatitis promotes EpCAM positive cancer stem cells mediated tumorigenesis in immunocompetent mouse model of hepatocellular carcinoma
Pandit, Harshul
Li, Yan
Cui, Guozhen
Li, Suping
Li, Salina
Martin, Robert C.
CANCER RESEARCH, 2017, 77
[27] Quantified postsurgical small cell size CFCs and EpCAM+ circulating tumor stem cells with cytogenetic abnormalities in hepatocellular carcinoma patients determine cancer relapse
Wang, Liang
Li, Yilin
Xu, Jing
Zhang, Aiqun
Wang, Xuedong
Tang, Rui
Zhang, Xinjing
Yin, Hongfang
Liu, Manting
Wang, Daisy Dandan
Lin, Peter Ping
Shen, Lin
Dong, Jiahong
CANCER LETTERS, 2018, 412 : 99 - 107
[28] Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients
R Schulze
M Schulze
A Wischnik
S Ehnle
K Doukas
W Behr
W Ehret
G Schlimok
Bone Marrow Transplantation, 1997, 19 : 1223 - 1228
[29] Tumor mutational burden (TMB), intratumoral genetic heterogeneity (ITGH) and BCG responsiveness in high-risk non-muscle invasive bladder cancer (NMIBC).
Bastos, Diogo Assed
Lima, Mariana
Mattedi, Romulo Loss
Dzik, Carlos
Ribeiro-Filho, Leopoldo
Cordeiro, Mauricio
Nahas, William Carlos
Souza, Jussara Michaloski
Amano, Mariane
Bettoni, Fabiana
Buzatto, Vanessa
dos Santos, Filipe Ferreira
Barreiro, Rodrigo
Favoretto Galante, Pedro Alexandre
Camargo, Anamaria Aranha
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[30] Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients
Schulze, R
Schulze, M
Wischnik, A
Ehnle, S
Doukas, K
Behr, W
Ehret, W
Schlimok, G
BONE MARROW TRANSPLANTATION, 1997, 19 (12) : 1223 - 1228

← 1 2 3 4 5 →